← Back to companies
Converge Bio
0 open
Wilmington, Delaware, United StatesFounded 202443+ employees$30.5M raisedSeries APrivate
Last round: series a · $25M · Jan 2026(3 rounds total)
Founded by Dov Gertz, Oded Kalev
Backed by(5 investors)
TLV PartnersBessemer Venture PartnersVintage Investment PartnersSaras CapitalAuroraAxis Capital
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
Open Positions at Converge Bio (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Converge Bio?
